Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX)
On February 9, David Westenberg from Piper Sandler maintained his Overweight rating on IDEXX Laboratories, Inc. (NASDAQ:IDXX).
Idexx Laboratories Inc (IDXX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fundsmith LLP Terry Smith | 1,876,035 | $1,269,193,959 | -29% | 7.42% |
| 2. | BAMCO Inc. Ron Baron | 1,798,041 | $1,216,428,678 | -5% | 3.3% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 550,368 | $372,340,463 | +198% | 0.22% |
| 4. | Select Equity Group Robert Joseph Caruso | 131,386 | $88,886,571 | -54% | 0.38% |
| 5. | AQR Capital Management Cliff Asness | 114,775 | $77,648,881 | -16% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $266.41 | 375 | $99,903.75 | 7,778 | 2019-08-06 | Filing | |
| $208.68 | 2,405 | $501,875.40 | 7,403 | 2019-02-05 | Filing | |
| $242.12 | 415 | $100,479.51 | 1,415 | 2018-08-03 | Filing | |
| $178.05 | 1,000 | $178,045.00 | 4,558 | 2018-02-14 | Filing | |
| $179.58 | 1,000 | $179,580.00 | 1,000 | 2018-02-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $663.04 | 2,589 | $1,716,620.66 | 83,606 | 2026-02-26 | Filing | |
| $662.16 | 1,000 | $662,156.70 | 86,195 | 2026-02-26 | Filing | |
| $661.10 | 1,200 | $793,317.12 | 87,195 | 2026-02-26 | Filing | |
| $659.75 | 2,859 | $1,886,223.82 | 88,395 | 2026-02-26 | Filing | |
| $658.92 | 3,660 | $2,411,634.76 | 91,254 | 2026-02-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,945,328 | $6,728,312,752 | 0.1% | |
| 2. | 8,534,886 | $5,774,106,652 | 0.1% | |
| 3. | 3,656,626 | $2,473,817,188 | 0.08% | |
| 4. | 2,583,939 | $1,749,379,966 | 0.11% | |
| 5. | 1,624,469 | $1,099,001,748 | 0.19% |
News See All
Here's What Analysts Are Saying About IDEXX Laboratories (IDXX)
IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the best pet stocks to buy according to hedge funds. On February 9, Piper Sandler cut the price target on IDEXX Laboratories, Inc.
10 Best Healthcare Equipment Stocks to Buy According to Hedge Funds
The Healthcare Equipment segment is one of the areas across the broader healthcare landscape that carries immense innovation prospects and also offers a defensive play.
10 Best Pet Stocks to Buy According to Hedge Funds
On February 12, Tom Lee of Fundstrat and Bitmine appeared on CNBC’s ‘Closing Bell’ to discuss the state of the markets and large themes moving stocks.
Here’s Why IDEXX Laboratories (IDXX) Shares are Re-Rating to Historical Average
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
IDEXX Laboratories Inc. (IDXX) Shows Resilience as Analysts Reassess Targets
IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best medical technology stocks to invest in. On February 3, BTIG lowered its price target on IDEXX Laboratories Inc.
10 Best Medical Technology Stocks to Invest In
Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.
Baron Partners Fund is Leveraging IDEXX Laboratories’ (IDXX) Long-Term Growth Drivers
Baron Fund, an investment management company, released its Q4 2025 letter for “Baron Partners Fund”. A copy of the letter can be downloaded here.
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. on MTC’s Substack. In this article, we will summarize the bulls’ thesis on IDXX.
IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market
Baron Funds, an investment management company, released its fourth-quarter investor letter for the “Baron Focused Growth Fund”. A copy of the letter can be downloaded here.
Hedge Fund Resource Center